Thu, Nov 12, 2026 - Page 18
13819 indexed SquawkNews stories from this UTC day. Showing 2041-2160.
L
Bolt Biotherapeutics Reports Q3 2026 Results; Advances PRA-216 Phase 2 Program
Bolt Biotherapeutics reported third-quarter 2026 collaboration revenue of zero and a net loss of $4.4 million, compared with revenue of $2.2 million and a net loss of $7.1 million a year earlier. The company completed it
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
CRESCENT BIOPHARMA INC Q3 INCOME FROM OPERATIONS USD -39.907 MILLION VS. IBES ESTIMATE USD -29.2 MILLION
CRESCENT BIOPHARMA INC Q3 INCOME FROM OPERATIONS USD -39.907 MILLION VS. IBES ESTIMATE USD -29.2 MIL
FX | Nov 12, 2026, 09:15 PM UTC
L
Net Power Reports Third Quarter 2026 Results and Provides Business Update
HOUSTON--(BUSINESS WIRE)-- Net Power Inc. (NYSE: NPWR) (“Net Power” or the “Company”) today announce
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
INNVENTURE INC Q3 OPERATING INCOME USD -351.378 MILLION
INNVENTURE INC Q3 OPERATING INCOME USD -351.378 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
INTELLINETICS Q3 EPS USD -0.05
INTELLINETICS Q3 EPS USD -0.05
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
FGI INDUSTRIES Q3 GROSS PROFIT USD 8.7 MILLION
FGI INDUSTRIES Q3 GROSS PROFIT USD 8.7 MILLION
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
KinderCare Reports Third Quarter 2026 Financial Results
KinderCare Learning Companies, Inc. (NYSE:KLC) (“KinderCare,” the “Company,” and “we”), a leading provider of high-quality early childhood education, today announced financial results for the third quarter ended October
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
NET POWER REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES BUSINESS UPDATE
NET POWER REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Marpai Reports Third Quarter 2026 Financial Results
Marpai Returns to Revenue Growth in Third Quarter 2026, Achieving First Year-Over-Year and Sequentia
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
Intellinetics 3Q Loss/Shr 5c >INLX
Intellinetics 3Q Loss/Shr 5c >INLX
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
KINDERCARE LEARNING COMPANIES INC OUTLOOK FY ADJUSTED EBITDA USD 190-195 MILLION VS. IBES ESTIMATE USD 206.7 MILLION
KINDERCARE LEARNING COMPANIES INC OUTLOOK FY ADJUSTED EBITDA USD 190-195 MILLION VS. IBES ESTIMATE U
FX | Nov 12, 2026, 09:15 PM UTC
L
FGI INDUSTRIES Q3 REVENUE USD 31.7 MILLION
FGI INDUSTRIES Q3 REVENUE USD 31.7 MILLION
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
KINDERCARE LEARNING COMPANIES INC Q3 NET INCOME USD -85 MILLION
KINDERCARE LEARNING COMPANIES INC Q3 NET INCOME USD -85 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
INTELLINETICS REPORTS IMPROVED THIRD-QUARTER PROFITABILITY AND GROSS MARGIN EXPANSION
INTELLINETICS REPORTS IMPROVED THIRD-QUARTER PROFITABILITY AND GROSS MARGIN EXPANSION
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Crescent Biopharma 3Q Loss/Shr 90c >CBIO
Crescent Biopharma 3Q Loss/Shr 90c >CBIO
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Net Power Reports Third Quarter 2026 Results and Provides Business Update
Net Power Inc. (NYSE:NPWR) (“Net Power” or the “Company”) today announced its financial and operational results for the third quarter ended September 30, 2026.“This past quarter, we recalibrated our strategy to what data
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Royalty Pharma to Present at UBS Global Biopharma Conference
Royalty Pharma announced it will present at the UBS Global Biopharma Conference.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
NAKAMOTO REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS
NAKAMOTO REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
ANDERSEN GROUP Q3 REVENUE USD 337.3 MILLION VS. IBES ESTIMATE USD 333.6 MILLION
ANDERSEN GROUP Q3 REVENUE USD 337.3 MILLION VS. IBES ESTIMATE USD 333.6 MILLION
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
VICI Properties Adds $500 Million Five-Year Unsecured Term Loan
VICI Properties said its subsidiary closed an amendment to its existing credit agreement adding a new $500 million unsecured term loan.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
KINDERCARE LEARNING COMPANIES INC Q3 ADJUSTED EPS USD -0.03 VS. IBES ESTIMATE USD -0
KINDERCARE LEARNING COMPANIES INC Q3 ADJUSTED EPS USD -0.03 VS. IBES ESTIMATE USD -0
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update Jemperli gl
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
THE RMR GROUP INC. ANNOUNCES FISCAL FOURTH QUARTER 2026 RESULTS
THE RMR GROUP INC. ANNOUNCES FISCAL FOURTH QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
ENERGOUS CORPORATION Q3 NET INCOME USD -2.51 MILLION
ENERGOUS CORPORATION Q3 NET INCOME USD -2.51 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
ENSYSCE BIOSCIENCES Q3 NET INCOME USD -82.3 MILLION
ENSYSCE BIOSCIENCES Q3 NET INCOME USD -82.3 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
United States Antimony Q3 Revenue Rises 16% to $10.1 Million
United States Antimony reported third-quarter 2026 revenue of $10.1 million, up 16% year over year, and gross profit of $4.3 million, with a 42% gross margin. The company recorded an operating loss of $6.0 million and a
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
onsemi Replaces Credit Agreement With $1.75 Billion Revolving Facility Maturing in 2031
onsemi entered into an amended and restated credit agreement providing a $1.75 billion revolving facility arranged by JPMorgan Chase and other lenders. It matures November 12, 2031, subject to a springing maturity tied t
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Beeline Holdings Q3 revenue rises sequentially on product mix shift
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
BioCardia Reports Q3 2026 Net Loss of $1.8 Million
BioCardia reported a net loss of $1.8 million for the third quarter of 2026, compared with a net loss of $1.5 million a year earlier. Cash and cash equivalents totaled $2.2 million at September 30, 2026, and net cash use
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
FGI INDUSTRIES Q3 ADJUSTED NET INCOME USD -700 THOUSAND
FGI INDUSTRIES Q3 ADJUSTED NET INCOME USD -700 THOUSAND
FX | Nov 12, 2026, 09:15 PM UTC
L
News Corp to Participate in Morgan Stanley European TMT Conference
News Corp said Chief Executive Robert Thomson will participate in the conference.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
MARPAI Q3 OPERATING INCOME USD -2.5 MILLION
MARPAI Q3 OPERATING INCOME USD -2.5 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
Alumis Reports Q3 2026 Results, $94.9 Million Net Loss
Alumis reported third-quarter 2026 revenue of $1.9 million and a net loss of $94.9 million. The company ended September with $431.3 million in cash, cash equivalents and marketable securities, which it expects to fund op
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
Realty Income Announces Chief Strategy Officer Transition
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Andersen Group Reports Third Quarter Revenue Growth of 18.7% to $337.3 Million
Andersen Group Inc. (NYSE:ANDG) today reported strong financial results for the third quarter ended September 30, 2026, with revenue increasing 18.7% to $337.3 million, driven by continued double-digit growth and an expa
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
ANAPTYSBIO Q3 NET INCOME USD 3.876 MILLION
ANAPTYSBIO Q3 NET INCOME USD 3.876 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
Candel Therapeutics Reports Q3 2026 Results, $203.1 Million in Cash
Candel Therapeutics reported a third-quarter 2026 net loss of $21.9 million, compared with a loss of $11.3 million a year earlier. Cash and cash equivalents were $203.1 million at September 30, which the company expects
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
CRESCENT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
CRESCENT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
The RMR Group Inc. Announces Fiscal Fourth Quarter 2026 Results
NEWTON, Mass.--(BUSINESS WIRE)-- The RMR Group Inc. (Nasdaq: RMR) today announced its financial resu
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
BIO GREEN MED SOLUTION INC Q3 NET INCOME USD -449 THOUSAND
BIO GREEN MED SOLUTION INC Q3 NET INCOME USD -449 THOUSAND
FX | Nov 12, 2026, 09:15 PM UTC
L
Enhanced Group Reports Q3 2026 Results, Posts $13.5 Million Net Loss
Enhanced Group reported third-quarter 2026 revenue of $3.3 million and a net loss of $13.5 million, compared with no revenue and a $5.9 million net loss in the year-ago quarter. Adjusted EBITDA was a loss of $8.8 million
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
BIO GREEN MED SOLUTION INC Q3 OPERATING INCOME USD -520 THOUSAND
BIO GREEN MED SOLUTION INC Q3 OPERATING INCOME USD -520 THOUSAND
FX | Nov 12, 2026, 09:15 PM UTC
L
FGI INDUSTRIES Q3 GROSS MARGIN 27.6%
FGI INDUSTRIES Q3 GROSS MARGIN 27.6%
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
FGI Industries Announces Third Quarter 2026 Results
FGI Industries Announces Third Quarter 2026 Results EAST HANOVER, NJ / ACCESS Newswire / November 12
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Agilent to Participate in Evercore Healthcare Conference
Agilent announced it will participate in the 9th Annual Evercore Healthcare Conference.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Energous 3Q Loss/Shr 45c >WATT
Energous 3Q Loss/Shr 45c >WATT
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights Compl
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
VICI Properties Announces $500 Million Five-Year Unsecured Term Loan
VICI Properties also amended its revolving credit facility pricing grid and partially redeemed notes due February 2027.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
NorthStar Plans Constellation Expansion With PIPE Proceeds
NorthStar Earth & Space plans to fund a constellation expansion with proceeds from a PIPE financing.
EQUITY | Nov 12, 2026, 09:15 PM UTC
M
VICI Properties Announces $500 Million Five-Year Unsecured Term Loan
VICI Properties announced a new $500 million, five-year unsecured term loan.
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
NEKTAR THERAPEUTICS Q3 NET INCOME USD -55.651 MILLION
NEKTAR THERAPEUTICS Q3 NET INCOME USD -55.651 MILLION
FX | Nov 12, 2026, 09:15 PM UTC
L
Nektar Therapeutics 3Q Rev $9.39M >NKTR
Nektar Therapeutics 3Q Rev $9.39M >NKTR
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Completed dose escalation in Phase 1/2 ASCEND trial of CR-001 with more than 125 patients dosed acro
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
NeoVolta Reports Financial Results for Quarter Ended September 30, 2026
NeoVolta Reports Financial Results for Quarter Ended September 30, 2026 Residential revenue rebounds
EARNINGS | Nov 12, 2026, 09:15 PM UTC
L
Nektar Therapeutics 3Q Loss/Shr $1.63 >NKTR
Nektar Therapeutics 3Q Loss/Shr $1.63 >NKTR
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE KUALA LU
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Nektar Therapeutics 3Q Loss $55.7M >NKTR
Nektar Therapeutics 3Q Loss $55.7M >NKTR
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress — Foll
EQUITY | Nov 12, 2026, 09:15 PM UTC
L
Shimmick 3Q Rev $135.8M >SHIM
Shimmick 3Q Rev $135.8M >SHIM
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Shimmick 3Q EPS 2c >SHIM
Shimmick 3Q EPS 2c >SHIM
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Lineage Cell Therapeutics swings to Q3 net income of $4.23 million
Lineage Cell Therapeutics swings to Q3 net income of $4.23 million Lineage Cell Therapeutics swu
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Once Upon a Farm Q3 net loss narrows 66% to $3.81 million; Q3 net sales rise 35% to $89.07 million
Once Upon a Farm Q3 net loss narrows 66% to $3.81 million; Q3 net sales rise 35% to $89.07 million
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
INTELLICHECK Q3 EPS USD 0.02
INTELLICHECK Q3 EPS USD 0.02
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Journey Medical's Q3 revenue rises on Emrosi demand but misses estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
ANDERSEN GROUP - Q3 REVENUE UP 18.7% TO $337.30 MLN - SEC FILING
ANDERSEN GROUP - Q3 REVENUE UP 18.7% TO $337.30 MLN - SEC FILING
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Virgin Galactic's Q3 net loss narrows on lower operating expenses; revenue beats estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Journey Medical's Q3 revenue rises on Emrosi demand but misses estimates
Journey Medical's Q3 revenue rises on Emrosi demand but misses estimates Overview US dermatology dru
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Snail Q3 net income swings to $6.7 million; Q3 net revenues more than double to $33.1 million
Snail Q3 net income swings to $6.7 million; Q3 net revenues more than double to $33.1 million Sn
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Once Upon a Farm Sees FY26 Adjusted EBITDA1 Loss of $4.5 M to $7 M >OFRM
Once Upon a Farm Sees FY26 Adjusted EBITDA1 Loss of $4.5 M to $7 M >OFRM
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
VirTra swings to Q3 net income of $2.2 million from year-earlier loss
VirTra swings to Q3 net income of $2.2 million from year-earlier loss VirTra swung to third-quar
EQUITY | Nov 12, 2026, 09:14 PM UTC
M
Virgin Galactic Q3 Loss Narrows as Revenue Beats Estimates
Virgin Galactic said its third-quarter net loss narrowed on lower operating expenses, while revenue exceeded estimates.
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
InspireMD Q3 revenue beats analyst estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:14 PM UTC
H
*-- Earnings Flash (TMC) TMC the metals company Posts Q3 Per-Share Loss $0.06, vs. FactSet Est. of $0.07 Loss
*-- Earnings Flash (TMC) TMC the metals company Posts Q3 Per-Share Loss $0.06, vs. FactSet Est.
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Vuzix Q3 revenue falls 38% on lower sales of discontinued smart glasses
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Merlin 3Q Rev $3.46M >MRLN
Merlin 3Q Rev $3.46M >MRLN
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
TransAct Narrows FY26 View To Sales $55M-$56M >TACT
TransAct Narrows FY26 View To Sales $55M-$56M >TACT
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
InspireMD Q3 revenue beats analyst estimates
InspireMD Q3 revenue beats analyst estimates Overview US carotid stent developer's Q3 revenue rose y
EARNINGS | Nov 12, 2026, 09:14 PM UTC
M
Vuzix Q3 Revenue Falls 38% on Lower Sales of Discontinued Smart Glasses
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Grown Rogue Q3 revenue rises on New Jersey performance
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Grown Rogue Q3 revenue rises on New Jersey performance
Grown Rogue Q3 revenue rises on New Jersey performance Overview US cannabis producer's Q3 revenue ro
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Enhanced Group Q3 net loss narrows 78% quarter-on-quarter to $13.46 million
Enhanced Group Q3 net loss narrows 78% quarter-on-quarter to $13.46 million Enhanced Group’s thi
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Once Upon a Farm Cuts FY26 View To Sales $290M-$300M >OFRM
Once Upon a Farm Cuts FY26 View To Sales $290M-$300M >OFRM
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
YDUQS Q3 ADJUSTED EBITDA 490 MLN REAIS VS IBES ESTIMATE 507 MLN REAIS
YDUQS Q3 ADJUSTED EBITDA 490 MLN REAIS VS IBES ESTIMATE 507 MLN REAIS
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
HireQuest Q3 net income drops 28% to $1.66 million; Q3 revenue rises to $8.81 million
HireQuest Q3 net income drops 28% to $1.66 million; Q3 revenue rises to $8.81 million HireQuest’
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
YDUQS Q3 ADJUSTED EBITDA 490 MLN REAIS VS IBES ESTIMATE 507 MLN REAIS
YDUQS Q3 ADJUSTED EBITDA 490 MLN REAIS VS IBES ESTIMATE 507 MLN REAIS
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Five9 to Present at RBCCM and Barclays Technology Conferences
Five9 management will present at the RBCCM and Barclays technology conferences.
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Spruce Power swings to Q3 2026 net income attributable to stockholders of $6.03 million
Spruce Power swings to Q3 2026 net income attributable to stockholders of $6.03 million Spruce P
EQUITY | Nov 12, 2026, 09:14 PM UTC
L
Nubank improves 2026 efficiency ratio outlook as AI leads hiring slowdown
By Andre RomaniBrazilian digital lender Nubank NYSE:NU on Thursday posted third-quarter profit in line with analysts' estimates, while improving its efficiency ratio projections for the year partly due to an artificial i
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Journey Medical Reports $19.0 Million Revenue and Positive Adjusted EBITDA
Journey Medical reported third-quarter 2026 revenue of $19.0 million, up 8% year over year, and a GAAP net loss of $1.3 million. The company posted positive adjusted EBITDA of $3.5 million, or $0.12 per diluted share. Em
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Jefferson Capital Q3 Revenue Rises 23% to $185.5 Million; Net Income Reaches $46.9 Million
Jefferson Capital reported third-quarter 2026 revenue of $185.5 million, up 23% year over year, and net income of $46.9 million. Adjusted net income was $51.3 million, with adjusted EPS of $0.83. The company also reporte
EARNINGS | Nov 12, 2026, 09:14 PM UTC
L
Cisco reports first-quarter EPS of $1.14
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
LifeMD Sees 4Q Rev $46M-$49M >LFMD
LifeMD Sees 4Q Rev $46M-$49M >LFMD
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Nubank improves 2026 efficiency ratio outlook as AI leads hiring slowdown
Nubank improves 2026 efficiency ratio outlook as AI leads hiring slowdown By Andre Romani SAO PAULO,
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Assembly Biosciences Reports $20.3 Million Q3 Loss; Cash Runway Into 2029
Assembly Biosciences reported third-quarter 2026 collaboration revenue of $3.0 million and a net loss of $20.3 million, compared with revenue of $10.8 million and a $9.2 million net loss a year earlier. Loss per share wa
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
U.S. Global Investors Q1 FY27 net income drops 89% year over year to $171,000
U.S. Global Investors Q1 FY27 net income drops 89% year over year to $171,000 U.S.
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
LifeMD 3Q Rev $44.6M >LFMD
LifeMD 3Q Rev $44.6M >LFMD
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
LifeMD 3Q Loss/Shr 11c >LFMD
LifeMD 3Q Loss/Shr 11c >LFMD
EQUITY | Nov 12, 2026, 09:13 PM UTC
H
Mannatech Reports $8.9 Million Q3 Net Income on Non-Cash Tax Benefit
Mannatech reported third-quarter 2026 net sales of $24.9 million, down 14.7% from a year earlier, and operating income of $0.3 million. Net income was $8.9 million, primarily reflecting a $10.9 million non-cash income ta
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
ONCE UPON A FARM PBC OUTLOOK FY ADJUSTED EBITDA LOSS OF $4.5 MILLION TO $7 MILLION
ONCE UPON A FARM PBC OUTLOOK FY ADJUSTED EBITDA LOSS OF $4.5 MILLION TO $7 MILLION
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
SELLAS Life Sciences Reports Q3 2026 Results and $134.7 Million Cash Position
SELLAS Life Sciences reported a third-quarter 2026 net loss of $10.1 million, or $0.05 per share, compared with a $6.8 million loss, or $0.06 per share, a year earlier. Research and development and general and administra
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Fulcrum Therapeutics Agrees to Sell HbF Assets for About $7 Million
Fulcrum Therapeutics agreed to sell its early-stage fetal hemoglobin assets for approximately $7.0 million in cash.
MNA | Nov 12, 2026, 09:13 PM UTC
L
UK's Wise Group H1 net revenue rises 23% on customer growth
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
YDUQS Q3 ADJUSTED NET PROFIT 139 MLN REAIS VS IBES ESTIMATE 159 MLN REAIS
YDUQS Q3 ADJUSTED NET PROFIT 139 MLN REAIS VS IBES ESTIMATE 159 MLN REAIS
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
YDUQS Q3 ADJUSTED NET PROFIT 139 MLN REAIS VS IBES ESTIMATE 159 MLN REAIS
YDUQS Q3 ADJUSTED NET PROFIT 139 MLN REAIS VS IBES ESTIMATE 159 MLN REAIS
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Friday's FX Options Expiries
Via ForexFlow EUR/USD: 1.1210 (EU1.32b), 1.1275 (EU1.07b), 1.1100 (EU814.2m) USD/JPY: 158.50 ($1.51b), 159.00 ($679.7m), 153.00 ($600m) AUD/USD: 0.6900 (AUD1.31b), 0.7000 (AUD1.15b), 0.6800 (AUD736.4m) USD/CAD: 1.4200 ($
NEWS | Nov 12, 2026, 09:13 PM UTC
H
NeuroPace Inc.: Q3 Earnings Snapshot
MOUNTAIN VIEW, Calif. (AP) — MOUNTAIN VIEW, Calif.
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
UK's Wise Group H1 net revenue rises 23% on customer growth
UK's Wise Group H1 net revenue rises 23% on customer growth Overview UK cross-border payments firm's
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Akari Therapeutics (AKTX) Ends Q3 With $5.7M Cash, Plans Phase 1 in Mid-2027
Akari ended Q3 2026 with $5.7M in cash, versus $5.2M at Dec. 31, 2025, after receiving approximately $2.9M from warrant exercises. GLP toxicology studies began for AKTX-101; a mid-2027 Phase 1 trial is planned, subject t
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
ONCE UPON A FARM PBC OUTLOOK FY NET SALES $290 MILLION TO $300 MILLION
ONCE UPON A FARM PBC OUTLOOK FY NET SALES $290 MILLION TO $300 MILLION
EQUITY | Nov 12, 2026, 09:13 PM UTC
M
BioStem Raises 2026 Revenue Outlook to $28M–$29M
BioStem reported Q3 2026 revenue of $7.6 million, down from $10.5 million a year earlier, and raised its 2026 revenue outlook to $28 million–$29 million from $26 million–$29 million. Cash was $1.0 million at quarter-end;
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Rollins to Present at RBC and Bernstein Investor Conferences
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
SKYX Platforms Corp. (SKYX) Q3 Revenue Rose 7.4% to $25.7M
SKYX reported Q3 2026 revenue of $25.7M, up 7.4% from $23.9M a year earlier, its 11th consecutive quarter of year-over-year growth. Gross profit was $8.1M, up 11% from Q2 2026; cash, cash equivalents and restricted cash
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Relmada Therapeutics (RLMD) Reports 18-Month NDV-01 Results, Targets Year-End INDs
Relmada reported initial 18-month results from its ongoing Phase 2 NDV-01 study, citing extended durability of complete response and favorable tolerability. It remains on track to submit INDs for NDV-01 and sepranolone b
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Dyadic International (DYAI) Q3 Revenue Falls 61.4% to $449.1K
Dyadic's Q3 2026 revenue fell 61.4% to $449.1K from $1.2M a year earlier. Net loss narrowed to $1.4M from $2.0M; cash, restricted cash and investment-grade securities totaled $6.0M at September 30, 2026, versus $8.6M at
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
TOMI Environmental Solutions, Inc. (TOMZ) Q3 Revenue Rose 24% YoY; Operating Income Turned Positive
TOMI reported preliminary, unaudited Q3 2026 revenue growth of 24% year over year and 11% sequentially, and positive operating income for the first time since Q3 2024. Results remain subject to change pending review of c
EARNINGS | Nov 12, 2026, 09:13 PM UTC
M
U.S. Global Investors Q1 Revenue Rises 18% to $2.7M
Fiscal Q1 2027 operating income was $55K, compared with a $515K operating loss a year earlier. Net income was $171K, or $0.01 per share, versus $1.5M, or $0.12 per share, primarily due to lower investment income.
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
NU HOLDINGS SHARES RISE 1.9% TO ABOVE $12 AFTER THE BELL FOLLOWING RESULTS, OUTLOOK
NU HOLDINGS SHARES RISE 1.9% TO ABOVE $12 AFTER THE BELL FOLLOWING RESULTS, OUTLOOK
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentia
Initiated GLP toxicology studies of lead TROP2-targeted ADC AKTX-101 to enable planned Phase 1 trial in mid-2027New preclinical findings demonstrate anti-tumor activity in urothelial cancer models resistant to currently
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Park Dental Partners (PARK) Q3 Revenue Increased 6%
Park Dental Partners reported third-quarter 2026 revenue growth of 6%. The company updated its full-year 2026 outlook to reflect the Village Family acquisition, increased clinical-capacity investment and the third-quarte
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
SELLAS Life Sciences Group, Inc. (SLS) Expects REGAL Trial Results This Month
SELLAS reported Q3 2026 net loss of $10.1M, versus $6.8M in Q3 2025, and cash of approximately $134.7M at September 30, 2026. It expects topline results from the Phase 3 REGAL trial this month.Material DetailsContext by
EQUITY | Nov 12, 2026, 09:13 PM UTC